HomeHealthIndian scientists discover natural compound that accelerates diabetic wound

Indian scientists discover natural compound that accelerates diabetic wound

Date:

Related stories

‘History will judge you’: Catholic bishops warn MPs as Amendment Bill vote looms

HARARE – Zimbabwe’s Catholic bishops have condemned the proposed...

Simon Rudland takes on ZBC over claims of bankrolling coup plot

HARARE – Lawyers for Zimbabwean billionaire Simon Rudland have...

Charamba Weighs In on Fuel Price Hike, Warns of Fiscal Trade-Offs

HARARE – Presidential spokesperson George Charamba has defended Zimbabwe’s...

Woman awarded US$8 000 in adultery damages

ELIZABETH Masvimbo has won her court battle against Natasha...

US$2,7m bank heist: Brother tips off cops

A MAN who had been on the run for...

Putin’s order of witdrawal from EU energy markets being worked out — Kremlin

MOSCOW,- Moscow is currently considering whether it should proactively...

RESEARCHERS at Indian Nagaland University have discovered a naturally occurring plant compound, Sinapic acid, that significantly accelerates wound healing in diabetic conditions. This is reported by ANI, a partner of TV BRICS.

The breakthrough offers a promising step towards developing safe, affordable, and natural treatments for one of diabetes’ most persistent complications – delayed wound recovery.

This is the first global study to demonstrate that Sinapic acid, when taken orally, enhances diabetic wound healing in preclinical models. The compound works by activating the SIRT1 pathway, a key mechanism responsible for tissue regeneration, blood vessel formation, and inflammation control.

The multidisciplinary project brought together scientists specialising in biotechnology, pharmacology, biochemistry, and medical sciences.

Exploring a plant-based alternative, the researchers found that Sinapic acid stimulates tissue repair, reduces inflammation, and promotes angiogenesis. Interestingly, a lower dose (20 mg/kg) proved more effective than a higher one, a finding known as an “inverted dose-response” pattern, which may influence future clinical applications.

The discovery could have a transformative impact on diabetic wound management by reducing amputation risks and providing a cost-effective therapy for patients in rural regions.

Future research will focus on advancing this innovation through molecular pathway analysis, safety and toxicity studies, formulation development, and pilot clinical trials in diabetic patients to confirm efficacy and safety.

(TVBRICS)

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

spot_img